• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有胸痛但冠状动脉无阻塞的女性中,冠状动脉造影与冠状动脉功能检查的诊断效果和临床应用价值。

Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries.

机构信息

Yale New Haven Hospital New Haven New Haven CT.

Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine New Haven CT.

出版信息

J Am Heart Assoc. 2024 Oct;13(19):e035852. doi: 10.1161/JAHA.124.035852. Epub 2024 Sep 18.

DOI:10.1161/JAHA.124.035852
PMID:39291500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11681466/
Abstract

BACKGROUND

Approximately 50% of women referred for invasive coronary angiography have angina and nonobstructive coronary arteries, which includes coronary microvascular dysfunction, vasospastic angina, and other vasomotor disorders. We sought to determine the real-world diagnostic yield of invasive coronary angiography and coronary function testing in women with angina and nonobstructive coronary arteries.

METHODS AND RESULTS

From 2018 to 2023, we enrolled 198 women who underwent either coronary angiography (CA) alone (n=99) or coronary function testing (CFT; n=99). Mean±SD age was 62±10 years (CA alone) compared with 57±10 years (CFT). Coronary angiography was interpreted as nonobstructive coronary artery disease more frequently after CA alone (79% versus 52%). Of the women who underwent CFT, 82% (N=81) were found to have vasomotor disorders, including coronary microvascular dysfunction (27%), vasospastic angina (32%), mixed coronary microvascular dysfunction/vasospastic angina (16%), endothelial dysfunction (10%; without spasm), elevated resting flow (2%), or symptomatic myocardial bridging (4%). Compared with women undergoing CA alone, medications were changed more frequently after CFT at 24 hours (41% versus 65%; =0.001) and between 24 hours and 30 days (30% versus 44%; =0.04) with intensification of antianginal therapy (79% versus 92%; 0.0001) and increased use of calcium channel blockers (36% versus 63%; 0.0001).

CONCLUSIONS

Our findings demonstrate that women presenting with suspected ischemic heart disease undergoing CA alone only received an anatomic diagnosis, whereas >80% of women undergoing CFT received a specific diagnosis of a coronary vasomotor disorder and greater intensification of antianginal therapy.

摘要

背景

约有 50%因疑似缺血性心脏病而行有创冠状动脉造影检查的女性患者其冠状动脉无明显狭窄,包括冠状动脉微血管功能障碍、痉挛性心绞痛和其他血管舒缩功能障碍。我们旨在确定在有症状且冠状动脉无明显狭窄的女性患者中行有创冠状动脉造影检查和冠状动脉功能检查的实际诊断效果。

方法和结果

在 2018 年至 2023 年期间,我们纳入了 198 名女性患者,其中 99 名患者仅接受了冠状动脉造影检查(CA 组),99 名患者接受了冠状动脉功能检查(CFT 组)。CA 组的平均年龄为 62±10 岁,CFT 组为 57±10 岁。CA 组冠状动脉造影检查结果为非阻塞性冠心病的比例更高(79% 比 52%)。行 CFT 的患者中,82%(81 名)存在血管舒缩功能障碍,包括冠状动脉微血管功能障碍(27%)、痉挛性心绞痛(32%)、混合性冠状动脉微血管功能障碍/痉挛性心绞痛(16%)、内皮功能障碍(10%;无痉挛)、静息血流升高(2%)或有症状性心肌桥(4%)。与仅行 CA 的女性患者相比,CFT 后 24 小时(41%比 65%;=0.001)和 24 小时至 30 天(30%比 44%;=0.04)药物改变更频繁,抗心绞痛治疗强化(79%比 92%;0.0001)和钙通道阻滞剂使用增加(36%比 63%;0.0001)。

结论

我们的研究结果表明,因疑似缺血性心脏病而行 CA 的女性患者仅获得解剖学诊断,而>80%行 CFT 的女性患者获得了冠状动脉血管舒缩功能障碍的明确诊断,并接受了更强化的抗心绞痛治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11681466/155ea259d3a4/JAH3-13-e035852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11681466/f1bcfe169690/JAH3-13-e035852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11681466/155ea259d3a4/JAH3-13-e035852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11681466/f1bcfe169690/JAH3-13-e035852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11681466/155ea259d3a4/JAH3-13-e035852-g001.jpg

相似文献

1
Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries.在有胸痛但冠状动脉无阻塞的女性中,冠状动脉造影与冠状动脉功能检查的诊断效果和临床应用价值。
J Am Heart Assoc. 2024 Oct;13(19):e035852. doi: 10.1161/JAHA.124.035852. Epub 2024 Sep 18.
2
Multivessel Coronary Function Testing Increases Diagnostic Yield in Patients With Angina and Nonobstructive Coronary Arteries.多血管冠状动脉功能检测可提高心绞痛伴非阻塞性冠状动脉疾病患者的诊断效果。
JACC Cardiovasc Interv. 2024 May 13;17(9):1091-1102. doi: 10.1016/j.jcin.2024.03.007.
3
Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.血管舒缩功能障碍在心绞痛和非阻塞性冠状动脉疾病患者中主要表现为血管痉挛。
Int J Cardiol. 2021 Jun 15;333:14-20. doi: 10.1016/j.ijcard.2021.02.079. Epub 2021 Mar 10.
4
CT Predictors of Epicardial Coronary Spasm in Patients With Angina and Nonobstructive Coronary Arteries.心绞痛和非阻塞性冠状动脉患者心外膜冠状动脉痉挛的CT预测因素
Circ Cardiovasc Imaging. 2025 Apr;18(4):e017565. doi: 10.1161/CIRCIMAGING.124.017565. Epub 2025 Mar 21.
5
Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina.在血管痉挛性心绞痛中,心绞痛严重程度和症状改善与诊断性乙酰胆碱激发剂量相关。
J Am Heart Assoc. 2025 Jan 21;14(2):e037913. doi: 10.1161/JAHA.124.037913. Epub 2025 Jan 16.
6
Prevalence of Coronary Vasomotor Disorders in Patients With Angina and Nonobstructive Coronary Arteries: A Sydney Experience.心绞痛伴非阻塞性冠状动脉疾病患者的冠状动脉舒缩功能障碍患病率:悉尼经验。
Heart Lung Circ. 2024 Sep;33(9):1297-1306. doi: 10.1016/j.hlc.2024.02.020. Epub 2024 Jun 25.
7
Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.心绞痛合并非阻塞性冠状动脉疾病患者的冠状动脉功能异常。
J Am Coll Cardiol. 2019 Nov 12;74(19):2350-2360. doi: 10.1016/j.jacc.2019.08.1056.
8
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.地尔硫䓬改善非冠状动脉粥样硬化性急性冠状动脉综合征患者冠状动脉血管运动功能障碍的疗效:EDIT-CMD 随机临床试验。
JACC Cardiovasc Imaging. 2022 Aug;15(8):1473-1484. doi: 10.1016/j.jcmg.2022.03.012. Epub 2022 Apr 2.
9
Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing: Netherlands Registry of Invasive Coronary Vasomotor Function Testing.有创冠状动脉功能测试的安全性、可行性及诊断率:荷兰有创冠状动脉血管舒缩功能测试注册研究
JAMA Cardiol. 2025 Apr 1;10(4):384-390. doi: 10.1001/jamacardio.2024.5670.
10
Relationship between peripheral and intracoronary blood flow in patients with angina and nonobstructive coronary arteries.心绞痛伴非阻塞性冠状动脉病变患者的外周与冠状动脉血流关系。
Am J Physiol Heart Circ Physiol. 2024 Oct 1;327(4):H1086-H1097. doi: 10.1152/ajpheart.00335.2024. Epub 2024 Aug 30.

本文引用的文献

1
Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries: Design and Rationale of the DISCOVER INOCA Prospective, Multicenter Registry.确定缺血性和非阻塞性冠状动脉患者冠状动脉血管舒缩障碍的病因:DISCOVER INOCA前瞻性多中心注册研究的设计与原理
J Soc Cardiovasc Angiogr Interv. 2024 May 3;3(6):102046. doi: 10.1016/j.jscai.2024.102046. eCollection 2024 Jun.
2
Coronary Microvascular Dysfunction.冠状动脉微血管功能障碍
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;3(3Part A):101230. doi: 10.1016/j.jscai.2023.101230. eCollection 2024 Mar.
3
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial.
有症状但冠状动脉无阻塞的患者的侵袭性内表型诊断:一项随机对照试验。
Circulation. 2024 Jan 2;149(1):7-23. doi: 10.1161/CIRCULATIONAHA.123.064751. Epub 2023 Oct 5.
4
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.心源性卒中的综合管理,第 1 部分-定义、患者人群和诊断:JACC 最新观点述评。
J Am Coll Cardiol. 2023 Sep 19;82(12):1245-1263. doi: 10.1016/j.jacc.2023.06.043.
5
Reply: Ischemia With Nonobstructive Coronary Artery Disease.回复:非阻塞性冠状动脉疾病伴缺血
JACC Asia. 2023 Jul 25;3(4):687. doi: 10.1016/j.jacasi.2023.06.003. eCollection 2023 Aug.
6
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
7
Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international.无阻塞性冠状动脉疾病的心肌缺血(INOCA):来自INOCA国际组织的患者生活质量自我报告调查
Int J Cardiol. 2023 Jan 15;371:28-39. doi: 10.1016/j.ijcard.2022.09.047. Epub 2022 Sep 23.
8
Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.非阻塞性冠状动脉疾病患者中冠状动脉微血管疾病和冠状动脉痉挛的患病率:系统评价和荟萃分析。
J Am Heart Assoc. 2022 Apr 5;11(7):e023207. doi: 10.1161/JAHA.121.023207. Epub 2022 Mar 18.
9
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28.
10
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.《女性非阻塞性 CAD 降低事件的缺血试验(WARRIOR)试验的原理和设计》。
Am Heart J. 2021 Jul;237:90-103. doi: 10.1016/j.ahj.2021.03.011. Epub 2021 Mar 18.